Guggenheim Capital’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $529K | Buy |
25,995
+1,212
| +5% | +$24.7K | ﹤0.01% | 1157 |
|
|
2025
Q1 | $450K | Buy |
24,783
+986
| +4% | +$17.9K | ﹤0.01% | 1242 |
|
|
2024
Q4 | $601K | Buy |
+23,797
| New | +$601K | ﹤0.01% | 1178 |
|
|
2017
Q3 | – | Sell |
-1,235
| Closed | -$44K | – | 2805 |
|
|
2017
Q2 | $44K | Sell |
1,235
-197
| -14% | -$7.02K | ﹤0.01% | 2742 |
|
|
2017
Q1 | $77K | Sell |
1,432
-141
| -9% | -$7.58K | ﹤0.01% | 2709 |
|
|
2016
Q4 | $84K | Sell |
1,573
-140
| -8% | -$7.48K | ﹤0.01% | 2780 |
|
|
2016
Q3 | $104K | Sell |
1,713
-202
| -11% | -$12.3K | ﹤0.01% | 2724 |
|
|
2016
Q2 | $127K | Sell |
1,915
-247
| -11% | -$16.4K | ﹤0.01% | 2710 |
|
|
2016
Q1 | $123K | Sell |
2,162
-18,346
| -89% | -$1.04M | ﹤0.01% | 2747 |
|
|
2015
Q4 | $4.82M | Sell |
20,508
-7,119
| -26% | -$1.67M | 0.01% | 1034 |
|
|
2015
Q3 | $4.37M | Buy |
27,627
+3,942
| +17% | +$623K | 0.01% | 1115 |
|
|
2015
Q2 | $8.96M | Buy |
23,685
+5,881
| +33% | +$2.22M | 0.02% | 883 |
|
|
2015
Q1 | $7.44M | Sell |
17,804
-853
| -5% | -$357K | 0.02% | 978 |
|
|
2014
Q4 | $5.11M | Buy |
18,657
+1,761
| +10% | +$482K | 0.01% | 1111 |
|
|
2014
Q3 | $3.29M | Buy |
16,896
+2,525
| +18% | +$491K | 0.01% | 1401 |
|
|
2014
Q2 | $3.52M | Sell |
14,371
-1,520
| -10% | -$372K | 0.01% | 1374 |
|
|
2014
Q1 | $4.21M | Buy |
15,891
+2,834
| +22% | +$751K | 0.01% | 1217 |
|
|
2013
Q4 | $4.74M | Buy |
13,057
+2,386
| +22% | +$867K | 0.01% | 1108 |
|
|
2013
Q3 | $5.67M | Sell |
10,671
-2,177
| -17% | -$1.16M | 0.02% | 1028 |
|
|
2013
Q2 | $3.01M | Buy |
+12,848
| New | +$3.01M | 0.01% | 1290 |
|